Expert Roundtable Gaining critical characterization insights for development of CAR-T Therapies for Solid Tumors Published: July 29, 2019 Cellular Immuno-Oncology 4.0 Sadik Kassim, Janani Krishnamurthy, Tamara J Laskowski & John O’Rourke Sadik Kassim Executive Director, Kite Pharma, A Gilead Company With a CV boasting the likes of Johnson & Johnson, the NIH, Novartis and Mustang Bio, Dr Sadik Kassim brings a wealth of experience and expertise spanning rare diseases, AAV-based gene therapy,...